What is Simponi 50 mg?
Simponi is the brand name for golimumab, a prescription medicine in the TNF (tumor necrosis factor) inhibitor drug class. Simponi 50 mg typically refers to a 50 mg dose strength of golimumab given by injection. It’s used for certain inflammatory conditions where TNF plays a role [1].
What conditions is Simponi (50 mg) used to treat?
Simponi (golimumab) is used for inflammatory diseases such as:
- Rheumatoid arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Ulcerative colitis [1]
How is Simponi 50 mg taken (injections)?
Simponi is given as an injection under the skin (subcutaneous). The exact schedule depends on the condition being treated and the prescribed regimen, so the dosing instructions on your prescription and medication guide matter [1].
What are common side effects people ask about?
Commonly reported issues with TNF inhibitors like golimumab can include injection-site reactions and upper respiratory infections (such as cold-like symptoms). Your clinician can review what to watch for based on your health history [1].
What serious risks should patients know about?
Because Simponi affects the immune system, it carries risks that require prompt medical attention, including:
- Serious infections
- Possible reactivation of infections (for example, tuberculosis or hepatitis) in people who have them
- Certain immune-related complications and changes in blood counts [1]
Who should not take Simponi 50 mg, or who needs extra screening?
People may need screening or may not be appropriate candidates depending on:
- History of serious or recurrent infections
- TB exposure or latent TB
- Hepatitis B status
- Current immunosuppressive therapy or active infections [1]
What happens if you miss a Simponi dose?
If you miss a dose, the correct next step depends on your dosing schedule. Follow the instructions provided by your prescriber or the medication guide for your specific regimen, and don’t double up without guidance.
Drug interactions: what should clinicians check?
TNF inhibitors can interact with other immunosuppressing or biologic therapies. Your prescriber should review all medicines you take, especially other biologics or strong immunosuppressants [1].
---
Sources
[1] https://www.fda.gov/drugs/resources-information-approved-drugs/simponi-golimumab-injection-and-simponi-aria-golimumab-injection